Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial
Authors:
- Albert ParésAPAlbert Parés
- Ramón PlanasRPRamón Planas
- Miguel TorresMTMiguel Torres
- Josep M. ViverJVJosep M. Viver
- Doroteo AceroDADoroteo Acero
- Juliá PanésJPJuliá Panés
- Joaquim RigauJRJoaquim Rigau
- Justiniano SantosJSJustiniano Santos
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (4) , 615-621
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Antioxidant activity of silybin in vivo during long-term iron overload in ratsGastroenterology, 1995
- Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake.Gut, 1994
- The prognosis of patients with alcoholic liver disease. An international randomized, placebo-controlled trial on the effect of malotilate on survivalJournal of Hepatology, 1994
- Serological and histological aspects of hepatitis C virus infection in alcoholic patientsJournal of Hepatology, 1991
- Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver diseaseJournal of Hepatology, 1991
- Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liverJournal of Hepatology, 1989
- Colchicine in the Treatment of Cirrhosis of the LiverNew England Journal of Medicine, 1988
- Long-Term Treatment of Alcoholic Liver Disease with PropylthiouracilNew England Journal of Medicine, 1987
- Silymarin treatment in alcoholic liver disease: A double blind randomized clinical trial (RC)Journal of Hepatology, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958